NCT07498114Completed
Association Between Fatigue Severity and Health-Related Quality of Life in Individuals With Stroke
Fatigue Severity Independently Predicts Health-Related Quality of Life in Stroke Survivors: A Cross-Sectional Study
Source: ClinicalTrials.gov · Last updated 30 Mar 2026
Brief summary (registry, in English)
This observational cross-sectional study aims to examine the association between fatigue severity and health-related quality of life in individuals with stroke. Fatigue severity will be assessed using the Fatigue Severity Scale (FSS), and quality of life will be evaluated using the Nottingham Health Profile (NHP). The primary analysis will investigate the relationship between FSS total score and NHP total score and domain scores.
- Status (registry)
- Completed
- Study type
- Observational
- Enrollment
- 53 (actual)
- First submitted
- 23 Mar 2026
- Start date
- 5 Mar 2026
- Primary completion date
- 25 Mar 2026
- Lead sponsor
- Uskudar University
- Diseases
- Stroke
- NCT number
- NCT07498114
What you commit to
- Study type: Observational
- Participants enrolled: 53
- From 5 Mar 2026 to the primary completion date, 25 Mar 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- \-
Who the study is looking for
- Time since stroke: ≥ \[3\] months
- Able to understand and complete questionnaires (with/without assistance)
- Provides informed consent
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Üsküdar Üniversitesi Coordinator of this site? Confirm its status | Istanbul | Turkey (Türkiye) | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.